Achilles Therapeutics

$3.80 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Achilles Therapeutics

Achilles Therapeutics PLC provides pharmaceuticals products. The Company offers therapies that target truncal tumour neo-antigens. Achilles Therapeutics serves customers in the United Kingdom.

Stock Analysis

last close $4.03
1-mo return -18.9%
3-mo return -44.9%
avg daily vol. 61.35T
52-week high 18.95
52-week low 3.96
market cap. $164M
forward pe -
annual div. -
roe -28.3%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 47.9%
baraka

Subscribe now for daily local and international financial news

Subscribe